Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-25-007330
Filing Date
2025-01-30
Accepted
2025-01-29 20:16:07
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2429853d10_defa14a.htm DEFA14A 24112
2 GRAPHIC tm2429853d10_defa14aimg001.jpg GRAPHIC 389781
3 GRAPHIC tm2429853d10_defa14aimg002.jpg GRAPHIC 172607
4 GRAPHIC tm2429853d10_defa14aimg003.jpg GRAPHIC 317730
  Complete submission text file 0001104659-25-007330.txt   1238035
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36721 | Film No.: 25570774
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)